Ipamorelin, a New Growth-Hormone-Releasing Peptide, Induces Growth Hormone Release via Hypothalamic GHS-R1a in Conscious Rats Growth Hormone & IGF Research Ipamorelin demonstrated potent, dose-dependent GH release without affecting ACTH, cortisol, prolactin, FSH, LH, or TSH establishing it as the most selective growth hormone secretagogue known
They just become the new baseline
Most economists who use these types of tools only use it as a guidepost and not the only data point with regards to making decisions
In addition to injectable options, there is also an oral form of GLP-1 therapy available
For instance, Novo has also lined up more distribution partnerships than Lilly with telehealth firms and leading retail pharmacies to expand access to its GLP-1s
However, oral semaglutide (Rybelsus) can increase levothyroxine exposure, so TSH should be monitored when these medications are co-administered, and timing or dosage adjustments may be needed